EGFR‐TKI plus antiangiogenic agent combination therapy may reduce the incidence of EGFR‐TKI–associated interstitial lung disease in Asian

EGFR‐TKI plus antiangiogenic agent combination therapy may reduce the incidence of EGFR‐TKI–associated interstitial lung disease in Asian

Bibliographic Details
Main Authors: Tai‐Huang Lee, Hsiao‐Ling Chen, Ming‐Ju Tsai, Chih‐Jen Yang
Format: Article
Language:English
Published: Wiley 2022-11-01
Series:Kaohsiung Journal of Medical Sciences
Online Access:https://doi.org/10.1002/kjm2.12584

Internet

https://doi.org/10.1002/kjm2.12584

Similar Items